This key opinion leader (KOL) webinar features the findings of a newly published real-world outcomes study demonstrating that Pressure-Enabled Drug Delivery™ (PEDD™) delivers a 48% improvement in drug delivery to target tumors while reducing complications associated with off-target administration when compared with conventional embolization approaches.
Alexander S. Misono, MD, MBA, RPVI, Chief of Interventional Radiology at Hoag Hospital (Newport Beach, CA), joins to discuss the current treatment landscape for hepatocellular carcinoma (HCC) and liver metastases, how the new real-world evidence shapes patient selection and treatment strategy, and share clinical experience and case examples using the TriNav® Infusion System.
